The CLA Pharmaceutical licences provide comprehensive permissions to reuse STM related content quickly and confidently: 

  • Frictionless internal and regulatory content sharing.
  • Collaboration licence extension to enhance partnerships.
  • Streamline content repurposing for marketing, educational, and research materials.

These Pharmaceutical Licences have been developed following consultation with the pharmaceutical industry and the permissions included are designed to offer compliance solutions to healthcare companies for their everyday information and regulatory needs.

86%

of healthcare and pharmaceutical professionals copy from the content they use
Enquire about a Pharmaceutical Licence

Enquire now

Q&A with Springer Nature's Leslie Lansman

Ethical content sharing and the benefits of the CLA Pharmaceutical Licence

We discuss the complexities of lawful and ethical content reuse in the pharmaceutical sector with Leslie Lansman, Global Permissions Manager at Springer Nature, exploring how the CLA Pharmaceutical Licence safeguards companies and promotes ethical content sharing practices.

Read article

The right licence for your needs

  • Pharmaceutical Licence: Ideal for organisations seeking streamlined internal content sharing and regulatory compliance.
  • Multinational Pharmaceutical Licence: Designed for UK headquartered companies with offices or employees outside of the UK, ensuring consistent content rights internationally.
  • Extended Multinational Pharmaceutical Licence: For international organisations with headquarters outside of the UK but has offices in the UK.

Upgrade with a Pharmaceutical Collaboration Licence, which facilitates secure content sharing and seamless partnership with external collaborators. The Collaboration Licence is a free upgrade option available for either the Pharmaceutical Licence or the Multinational Pharmaceutical Licence. It allows sharing licensed copies among organisations that hold relevant CLA and Copyright Clearance Center (CCC) Licences.

You’ll receive all the same benefits as the CLA Pharmaceutical Licence, along with the ability to legally share copies with other licensed companies.

Start your licence enquiry

Discover how CLA can support your organisation to Copy, Right

The Pharmaceutical Licences are specifically created for the pharmaceutical and medical sectors

They contain permissions that aren’t included in other licences. In addition to the permissions found in the standard Business Licence that offer reuse permissions for millions of leading publications from the UK and 44 international territories, the Pharmaceutical Licence extensions have tailored features to support pharmaceutical and medical professionals directly.

 

Licence benefits

Icon depicting copying and sharing contentSimplified content sharing

Enjoy consistent rights for millions of peer-reviewed articles, clinical trial data, and industry reports.

Icon depicting copy limits

Flexible copying

Copy up to two articles, chapter or 5% of the total of a work – whichever is greater.

Icon depicting collaborative activities

Effortless collaboration

Forward copies via email, distribute hard copies to colleagues or save and store copies on shared drives.

Icon depicting collaboration across global teams
Global teams

Facilitates seamless collaboration across international teams.

Icon depicting circulation of press cuttings

Circulate with ease

Circulate press cuttings or fee-paid documents in digital or print form.

Icon depicting sharing medical informationExternal sharing

Share single licensed digital and print copies for medical information, legal proceedings, regulatory submissions and patent applications.

Icon depicting digital downloadStore digital copies

Store copies in a local product or project based database (including long term dim archives for regulatory purposes).

Icon depicting outsourcing permissions

Efficient permissions management

Outsource permissions to an onsite or offsite third party contractor.

The Pharmaceutical Licence helps distribute an average of

£3.3m

to rightsholders every year

Featured content

Supporting regulatory submission process

CLA’s Andy Greenan, looks at why a CLA pharmaceutical licence is invaluable for any company developing a new drug.

Content use and copying practices

Icon showing a magnifying glass over a document

Study by CLA on content use behaviours and copying practices amongst UK professionals, with a spotlight on the pharmaceutical sector.

Navigating your Pharmaceutical Licence

Sarah Johnson, Head of Licensing, answers essential FAQs on the CLA Pharmaceutical Licence.

What our customers say

Mundipharma logo

“Mundipharma is a global healthcare company dedicated to bringing innovative treatments to patients through clinical research, publications, and medical education. Our CLA Licence helps our colleagues feel comfortable in using scientific content for research, education and business needs. Having the right copyright licence from CLA allows us to move forward with our commitment to healthcare and patients worldwide, and show we are committed to ethical practice.”

 

Dr. Rick Lones – Global VP of Medical Affairs at Mundipharma Research Limited

Collaboration benefits of a CLA Pharmaceutical Licence

  • R&D: Share a PDF or article with colleagues to accelerate innovation and streamline project timelines.
  • Regulatory submissions: Send digital or paper copies to the regulatory authorities in any jurisdiction.
  • Internal presentations and training: Elevate internal training with evidence-based presentations using the latest research and industry insight.
  • Corporate comms: Stay on top of industry trends by sharing market reports and insights in company newsletters or intranets.
  • Market monitoring: Easily share competitive intelligence and market insights across teams, enabling data-driven decision making.
  • Medical Information and technical support: You may send digital and print copies to healthcare professionals and others making unsolicited requests for therapeutic or technical information about your company’s products.

Unlock STM content

  • Journal articles
  • Industry publications
  • Clinical trial reports
  • Whitepapers
  • Medical images and illustrations
  • Trade magazines

Top Copied Titles

Image showing two medical professionals looking at a document

International Solutions

  • Multinational Pharmaceutical Licence: Designed for non-UK headquartered companies ensuring consistent content rights internationally.
  • Extended Multinational Pharmaceutical Licence: For UK headquartered companies extending permissions to overseas sites and employees.

The Multinational Pharmaceutical Licence provides an annual blanket cover to copy and reuse content from print and digital publications. This includes access and reuse of STM content supplied directly by publishers or via other third-party content supply services.

Includes all UK publications plus publishers/imprints whose works can be copied whatever their country of publication. This includes major STM publishers such as Elsevier, Springer, Wiley and others – see full list at: cla.co.uk/international/territories

Our relationship with CCC in the USA also means that UK headquartered firms only require one licence for repertoire covered by CLA and CCC, providing consistent annual cover for all employees globally.

The licence provides annual blanket global cover for all employees, and:

  • Access to major STM publishers such Elsevier, Springer, Wiley and over 80 others
  • Permission to copy up to two articles, chapter or 5% of the total – whichever is greater
  • Circulate press cuttings or fee-paid documents in digital or print form
  • External sharing of single licensed digital and print copies for medical information, legal proceedings, regulatory submissions and patent applications
  • Outsource permissions to an onsite or offsite third-party contractor
  • Store digital copies in a local product or project-based database (including long term dim archives for regulatory purposes)

 

Start your licence enquiry

Licence support documents

Licence document – The T&Cs of your Licence

Licence rates – Licence fees from April 2024

Copying guidelines – Guidelines for your staff on making copies

Explanatory leaflet – A leaflet that explains the detail of your licence

Licence document – The T&Cs of your Licence

Explanatory leaflet – A leaflet that explains the detail of your licence

Copying guidelines – Guidelines for your staff on making copies

Licence document – The T&Cs of your Licence

Explanatory leaflet – A leaflet that explains the detail of your licence

Licence document – The T&Cs of your Licence